鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02251 鹰瞳科技-B

交易中 04-16 14:08:35

11.920

+0.120

+1.02%

最高12.300	最低11.410	成交量1.42万
今开12.100	昨收11.800	日振幅7.54%
总市值12.16亿	流通市值12.16亿	总股本1.02亿
成交额17.02万	换手率0.01%	流通股本1.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":11.92,"timestamp":1776319032443,"preClose":11.8,"halted":0,"volume":14200,"delay":0,"changeRate":0.010169491525423662,"floatShares":102000000,"shares":102000000,"eps":-0.2806804499064147,"marketStatus":"交易中","change":0.12,"latestTime":"04-16 14:08:35","open":12.1,"high":12.3,"low":11.41,"amount":170193,"amplitude":0.075424,"askPrice":12.07,"askSize":1500,"bidPrice":11.92,"bidSize":4900,"shortable":0,"etf":0,"ttmEps":-0.2806804499064147,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1776327000000},"marketStatusCode":2,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":11.8,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":0.440086,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251","defaultTab":"news","newsList":[{"id":"2627807052","title":"鹰瞳科技-B(02251)4月15日斥资41.61万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627807052","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627807052?lang=zh_cn&edition=full","pubTime":"2026-04-15 21:57","pubTimestamp":1776261424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月15日斥资41.61万港元回购3.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139717914","title":"鹰瞳科技-B回购3.5万股股份，总额约41.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139717914","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139717914?lang=zh_cn&edition=full","pubTime":"2026-04-15 21:56","pubTimestamp":1776261363,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年4月15日公告称，公司在香港联交所场内回购35,000股H股。本次回购股份数量占回购前公司已发行股本约0.034%，每股价格区间介乎港币11.40港元至12.09港元，总计支出416,051港元，折合约41.61万港元。根据公告，公司购回授权于2025年6月27日获通过，可回购最多10,315,601股。截至目前，公司已累计回购830,100股，占购回授权通过当日已发行股本的0.8047%。公司同时确认已遵守香港联交所上市规则及相关法律规定，公告由董事张大磊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627399426","title":"万东医疗新注册《IPS 医学影像处理软件1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2627399426","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627399426?lang=zh_cn&edition=full","pubTime":"2026-04-15 02:06","pubTimestamp":1776189976,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万东医疗（600055）新注册了《IPS 医学影像处理软件1》项目的软件著作权。今年以来万东医疗新注册软件著作权1个。结合公司2025年年报财务数据，2025年公司在研发方面投入了2.63亿元，同比增59.28%。通过天眼查大数据分析，北京万东医疗科技股份有限公司共对外投资了17家企业，参与招投标项目2749次；财产线索方面有商标信息317条，专利信息355条，著作权信息121条；此外企业还拥有行政许可84个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500002972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK1189","600055","02251","BK0070","BK0114","159180","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125783035","title":"鹰瞳科技-B：4月14日回购2.37万股，耗资约27.53万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125783035","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125783035?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:31","pubTimestamp":1776169896,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B（02251）于2026年4月14日发布公告称，公司在香港联交所场内回购2.37万股H股，占回购前已发行H股总数102,384,613股的约0.023%。本次回购每股价格介乎港币11.1元至11.99元，总涉资约27.53万港元。回购完成后，公司已发行股份（不含库藏股）数量降至102,360,913股，库藏股数量增至1,207,100股。\n根据公告，本次回购基于2025年6月27日获通过的购回授权。公司可购回股份总数为10,315,601股，截至目前已累计回购795,100股，占获授权购回上限约0.7708%。公司确认已遵守相关上市规则及法律法规，公告由董事张大磊签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627544664","title":"鹰瞳科技-B(02251)4月14日斥资27.5万港元回购2.37万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627544664","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627544664?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:26","pubTimestamp":1776169619,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月14日斥资27.5万港元回购2.37万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155214144","title":"鹰瞳科技-B回购6200股股份，耗资约6.71万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155214144","media":"公告速递","labels":["buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155214144?lang=zh_cn&edition=full","pubTime":"2026-04-08 20:02","pubTimestamp":1775649754,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年4月8日发布公告，披露在香港联交所场内回购股份事宜。公告显示，公司于2026年4月8日回购6200股H股，占当日回购前已发行股份的约0.006%。本次回购价格区间为每股10.78港元至11.09港元，总金额约6.71万港元。公司指出，此次回购依据2025年6月27日通过的购回授权进行。该授权可供公司回购的股份总数为10,315,601股，截至本次交易后，累计回购数量为771,400股，占授权通过当日已发行股份数目的0.7478%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625946865","title":"鹰瞳科技-B(02251)4月8日耗资约6.71万港元回购6200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2625946865","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625946865?lang=zh_cn&edition=full","pubTime":"2026-04-08 19:58","pubTimestamp":1775649496,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)公布，2026年4月8日耗资约6.71万港元回购6200股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183817257","title":"鹰瞳科技-B3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1183817257","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183817257?lang=zh_cn&edition=full","pubTime":"2026-04-08 18:26","pubTimestamp":1775644002,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司（股票代码：02251）于2026年4月8日披露了截至2026年3月31日的股份变动月报表。公告显示，公司注册股本为人民币103,568,013元，普通股（H股）总数103,568,013股，其中已发行股份（不包括库存股份）102,481,213股，库存股份1,086,800股，各项数据与上月底持平。公司期间未发生新增发行、购回或注销股份等变动，股本结构保持稳定。\n公告同时显示，当月并无涉及股票期权、权证、可换股票据或其他权益安排的变动事宜。公司确认已遵守香港联交所《上市规则》及相关法规。该报告由公司董事张大磊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625477993","title":"港股异动 | 德适-B(02526)涨超7% 核心业务为医学影像AI基座大模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2625477993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625477993?lang=zh_cn&edition=full","pubTime":"2026-04-08 09:46","pubTimestamp":1775612815,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，“医学影像大模型第一股”德适-B今早涨超7%，截至发稿，涨6.84%，报250港元，成交额1878.41万港元。此外，公司的核心产品AI AutoVision已获国家药品监督管理局认定为三类创新医疗器械，有望成为全国首款获批上市的智能染色体核型辅助诊断软件。2025年前9个月，公司实现营收同比激增469.8%达1.12亿元，毛利率高达75.9%，其中技术许可业务毛利率更是达到96.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIPO","VXUS","02526","CHAT","BK4585","ARTY","BK4588","02251","AGIX","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170599355","title":"鹰瞳科技-B：4月1日回购9.04万股，耗资约103.10万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170599355","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170599355?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:26","pubTimestamp":1775046363,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司（股票代码：02251）于2026年4月1日公告，回购H股90,400股，占当日公司已发行股本约0.088%。此次回购价格区间为每股11.00港元至11.79港元，总耗资约1,030,972港元（折合约103.10万港元）。\n此次回购后，公司已发行股份数量由102,481,213股降至102,390,813股，库藏股增至1,177,200股。公司购回授权于2025年6月27日获得通过，可回购股份总数为10,315,601股，迄今已回购765,200股，占授权当日已发行股本约0.7418%。\n公司确认已遵守相关上市规则与法律法规。公告由公司董事张大磊签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624851539","title":"鹰瞳科技-B(02251)4月1日斥资103.1万港元回购9.04万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624851539","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624851539?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:24","pubTimestamp":1775046279,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月1日斥资103.1万港元回购9.04万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424197.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144889425","title":"异动解读 | 业绩亏损大幅收窄，鹰瞳科技-B盘中大涨23.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144889425","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144889425?lang=zh_cn&edition=full","pubTime":"2026-04-01 10:58","pubTimestamp":1775012306,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B今日盘中股价大幅上涨23.5%，引起了市场的广泛关注。消息面上，公司公布了截至去年12月底的全年业绩。数据显示，公司营业额达到1.73亿元人民币，按年增长10.8%。更为关键的是，公司全年亏损大幅收窄至2，497.5万元人民币，而上年同期亏损高达2.55亿元人民币。业绩的显著改善，特别是亏损的大幅收窄，被市场视为积极的经营信号，提振了投资者信心，从而推动了股价在交易时段内的强劲表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533909","title":"鹰瞳科技-B(02251)发布2025年度业绩，股东应占亏损2497.5万元，同比收窄90.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533909","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623533909?lang=zh_cn&edition=full","pubTime":"2026-03-31 23:20","pubTimestamp":1774970456,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布截至2025年12月31日止年度业绩，收入1.73亿元(人民币，下同)，同比增长10.8%;母公司拥有人应占亏损2497.5万元，同比收窄90.2%;每股基本亏损0.24元。期内亏损减少主要由于加强渠道管理，价格体系管理有效提高产品毛利率;从研发、生产到销售、中后台服务支持全链条引入大模型，大幅提高效率，直接降低人工成本、降低第三方服务机构的依赖，节约服务费支出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"鹰瞳科技-B(02251)发布2025年度业绩，股东应占亏损2497.5万元，同比收窄90.2%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623602193","title":"“医学影像大模型第一股”德适IPO上市，开盘大涨121%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623602193","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623602193?lang=zh_cn&edition=full","pubTime":"2026-03-30 10:06","pubTimestamp":1774836360,"startTime":"0","endTime":"0","summary":"　　今日，港股再次迎来AI大模型的又一里程碑事件。德适正式登陆港交所，股票定价每股99港元，开盘股价大涨121%，达到219港元。今年以来，智谱、MINIMAX等AI大模型领域企业陆续登陆港交所，股价表现尤为亮眼。　　德适本次IPO成绩不可谓不亮眼。　　官方披露，本次德适拟发行799.2万股H股，公开发售占比10%、国际配售占比90%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-03-30/doc-inhsttqy4084480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623649863","title":"新股首日 | 德适-B(02526)首挂上市 早盘高开121.21% 公司深耕医学影像大模型平台赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2623649863","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623649863?lang=zh_cn&edition=full","pubTime":"2026-03-30 09:25","pubTimestamp":1774833939,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B首挂上市，公告显示，每股定价99港元，共发行799.92万股股份，每手50股，所得款项净额约7.198亿港元。截至发稿，涨121.21%，报219港元，成交额1.81亿港元。公开资料显示，德适生物深耕医学影像大模型平台赛道，于2025年推出iMedImage医学影像通用大模型，打造全球首个千亿级参数跨模态医学影像基座模型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8293f4390269cdf381911547aa08fd82","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","02526","BK1189"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621771299","title":"长线基金超购逾2倍：医学影像大模型第一股德适打新背后","url":"https://stock-news.laohu8.com/highlight/detail?id=2621771299","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621771299?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:37","pubTimestamp":1774258620,"startTime":"0","endTime":"0","summary":"医疗AI作为典型的高壁垒赛道，其商业化落地能力与技术路径，正成为资本市场关注的核心。　　3月20日，杭州德适生物科技股份有限公司正式启动港股IPO招股，拟发行7，999，200股H股，发售价区间为每股95.6至112.5港元。　　在递表港交所前，德适已完成十轮融资，累计募资约3.97亿元人民币。在此次IPO的国际配售环节中，公司获得多家长线基金认购并实现超额覆盖，认购规模超购逾2倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-23/doc-inhrynrr7919265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02251","02526","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621710180","title":"德适-B，流通股最少84亿，专注于医学影像AI产品及医疗器械——(02526.HK)2026年3月新股分析 原创 机构喵 机构喵 爱打新的猫 202","url":"https://stock-news.laohu8.com/highlight/detail?id=2621710180","media":"爱投资的小熊猫","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621710180?lang=zh_cn&edition=full","pubTime":"2026-03-22 22:14","pubTimestamp":1774188840,"startTime":"0","endTime":"0","summary":"上面发文章的这个微信公众号，主要是我们做机构业务为主的，更多的会以机构的视角来看待问题。所以大家也可以多看看，后续应该很多文章会在这里发。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-22/doc-inhrwpyr4762705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","09997","09996","BK1583","02251","BK1574","BK1100","02526","BK1189","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620209887","title":"德适今日启动港股IPO招股，将成“医学影像大模型第一股”","url":"https://stock-news.laohu8.com/highlight/detail?id=2620209887","media":"新浪科技","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620209887?lang=zh_cn&edition=full","pubTime":"2026-03-20 10:56","pubTimestamp":1773975360,"startTime":"0","endTime":"0","summary":"新浪科技讯 3月20日上午消息，杭州德适生物科技股份有限公司正式启动港股IPO招股，计划将于3月30日在港交所主板挂牌上市。此次IPO拟发行7，999，200股H股，发售价区间为每股95.6至112.5港元。其中香港公开发售占10%，国际发售占90%，至多可通过本次IPO募集约9亿港元。　　本次招股将于3月25日截止。在港交所主板挂牌上市后，德适将成为“医学影像大模型第一股”。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/newstock/2026-03-20/doc-inhrqyie0914872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK1189","VXUS","BK4588","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620036802","title":"“医学影像大模型第一股”问鼎港交所：德适生物（2526.HK）收入暴涨469.8%的底层逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2620036802","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620036802?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:15","pubTimestamp":1773969351,"startTime":"0","endTime":"0","summary":"作为港股市场稀缺的医疗AI核心资产，德适生物不仅为二级市场提供了兼具稀缺性与确定性的投资标的，更将引领中国医疗AI技术从“跟跑”迈向“领跑”，为健康中国建设注入强劲的数智动能。","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/137.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/137.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4126064","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02526","BK1189","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620776732","title":"德适-B(02526)3月20日至3月25日招股拟全球发售799.92万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620776732","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620776732?lang=zh_cn&edition=full","pubTime":"2026-03-20 07:28","pubTimestamp":1773962939,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德适-B 于2026年3月20日-2026年3月25日招股，拟全球发售799.92万股H股，其中香港发售占约10%，国际发售占约90%;发售价每股95.6-112.5港元。得益于需求不断增长、AI技术进步、医院信息系统发展以及利好政策，中国智能医学影像市场的市场规模预计到2030年将增加至人民币401亿元，2024年至2030年的复合年增长率为60.2%，到2035年将进一步增加至人民币781亿元，2030年至2035年的复合年增长率为14.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4543","VGT","BK1189","02251","BK4528","BK4023","AI","AIYY","BK4587","BK4585","BK4588","BK4551"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.064},{"period":"1month","weight":0.0225},{"period":"3month","weight":-0.0923},{"period":"6month","weight":-0.1114},{"period":"1year","weight":0.0747},{"period":"ytd","weight":0.0324}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.0044},{"period":"3month","weight":-0.0363},{"period":"6month","weight":0.0277},{"period":"1year","weight":0.2087},{"period":"ytd","weight":0.0124}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京鹰瞳科技发展股份有限公司是一家中国公司，主要专注于提供人工智能视网膜影像识别的早期检测诊断及健康风险评估解决方案。该公司的产品管线包括为医疗机构和大健康领域提供的眼底诊断人工智能SaMD、健康风险评估系统以及相应的智能硬件设备，打造了集软件和硬件于一体的解决方案。该公司还推出了针对儿童和青少年近视及斜弱视问题的人工智能治疗产品，实现了从检测、评估到治疗的一站式解决方案。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.071183},{"month":2,"riseRate":0.8,"avgChangeRate":0.116001},{"month":3,"riseRate":0.2,"avgChangeRate":-0.086289},{"month":4,"riseRate":0.2,"avgChangeRate":-0.014833},{"month":5,"riseRate":0.5,"avgChangeRate":-0.081691},{"month":6,"riseRate":0.5,"avgChangeRate":0.014792},{"month":7,"riseRate":0.25,"avgChangeRate":-0.034393},{"month":8,"riseRate":0.5,"avgChangeRate":-0.020416},{"month":9,"riseRate":0.25,"avgChangeRate":-0.059637},{"month":10,"riseRate":0.25,"avgChangeRate":-0.013194},{"month":11,"riseRate":0.75,"avgChangeRate":0.109538},{"month":12,"riseRate":0.4,"avgChangeRate":-0.09117}],"exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}